These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27473736)

  • 21. Systemic and targeted therapies for early-stage lung cancer.
    Byron E; Pinder-Schenck M
    Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum/etoposide therapy in non-small cell lung cancer.
    Bonomi P
    Oncology; 1992; 49 Suppl 1():43-50. PubMed ID: 1323811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.
    Roth JA; Goulart BH; Ravelo A; Kolkey H; Ramsey SD
    Oncologist; 2017 Mar; 22(3):304-310. PubMed ID: 28242792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative group clinical trials in general thoracic surgery: report from the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical Club.
    Allen MS; Wigle DA;
    Ann Thorac Surg; 2013 Feb; 95(2):750-6. PubMed ID: 23336898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
    Lyss AP; Lilenbaum RC
    Clin Lung Cancer; 2009 Nov; 10(6):410-3. PubMed ID: 19900858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
    Marco S; Tomasini P; Greillier L; Barlesi F
    Rev Mal Respir; 2011 Dec; 28(10):1216-29. PubMed ID: 22152931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
    Yang K; Wang YJ; Chen XR; Chen HN
    Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
    Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
    J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S; Fukuoka M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598.
    Langer CJ; Stephenson P; Thor A; Vangel M; Johnson DH;
    J Clin Oncol; 2004 Apr; 22(7):1180-7. PubMed ID: 14981103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC.
    Langer CJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):991-1002. PubMed ID: 14967461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientific Advances in Thoracic Oncology 2016.
    Soo RA; Stone ECA; Cummings KM; Jett JR; Field JK; Groen HJM; Mulshine JL; Yatabe Y; Bubendorf L; Dacic S; Rami-Porta R; Detterbeck FC; Lim E; Asamura H; Donington J; Wakelee HA; Wu YL; Higgins K; Senan S; Solomon B; Kim DW; Johnson M; Yang JCH; Sequist LV; Shaw AT; Ahn MJ; Costa DB; Patel JD; Horn L; Gettinger S; Peters S; Wynes MW; Faivre-Finn C; Rudin CM; Tsao A; Baas P; Kelly RJ; Leighl NB; Scagliotti GV; Gandara DR; Hirsch FR; Spigel DR
    J Thorac Oncol; 2017 Aug; 12(8):1183-1209. PubMed ID: 28579481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
    Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos HP; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
    Anticancer Res; 2006; 26(4B):3175-81. PubMed ID: 16886653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies.
    Acker F; Luan J; Soltani Germy P; Kemper M; Blasi M; Griesinger F; Tufman A; Bleckmann A; Kropf-Sanchen C; Overbeck TR
    Oncol Res Treat; 2024; 47(6):306-311. PubMed ID: 38527447
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
    Hoang T; Xu R; Schiller JH; Bonomi P; Johnson DH
    J Clin Oncol; 2005 Jan; 23(1):175-83. PubMed ID: 15625371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.